Literature DB >> 437649

[Pentoxifylline medication within the scope of leg-ulcer therapy. Results of a field study using Trental 400].

K Pemler, B Penth, H J Adams.   

Abstract

513 patients with chronic ulcers of the leg were treated with Trental 400 orally in addition to local therapy. Regarding the reduction of the symptoms: ulcer extension, coldness of the leg, paraesthesia, resting pain and improvement of walking distance, 215 patients were classified as considerably improved, 195 distinctly improved, 53 slightly improved and 44 unchanged. Four cases worsened, two cases could not be classified. The possibility of combining oral therapy with local treatment and surgical measures (skin-flaps) is shown in three case reports. Gastro-intestinal tolerance of Trental 400 was good, interactions with concomitantly administered drugs were not reported.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 437649

Source DB:  PubMed          Journal:  Fortschr Med        ISSN: 0015-8178


  3 in total

1.  Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers.

Authors:  J J Dale; C V Ruckley; D R Harper; B Gibson; E A Nelson; R J Prescott
Journal:  BMJ       Date:  1999-10-02

Review 2.  Pentoxifylline for treating venous leg ulcers.

Authors:  Andrew B Jull; Bruce Arroll; Varsha Parag; Jill Waters
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 3.  Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.

Authors:  A Ward; S P Clissold
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.